Cartesian Therapeutics
RNAC
$26.43
Share price
0.34%
Change (1 day)
2,281.08%
Change (1 year)
Categories
Cartesian Therapeutics (RNAC) - Cash on Hand
Cash on Hand as of December 2023 : $76.91 M
According to Cartesian Therapeutics's latest financial reports the company has $76.91 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Cartesian Therapeutics - Cash on Hand chart (from 2015 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $76.91 M | -42.86% |
| 2022-12-31 | $0.13 B | 5.11% |
| 2021-12-31 | $0.12 B | -7.66% |
| 2020-12-31 | $0.13 B | 54.28% |
| 2019-12-31 | $89.89 M | 140.34% |
| 2018-12-31 | $37.4 M | -61.3% |
| 2017-12-31 | $96.63 M | 14.85% |
| 2016-12-31 | $84.14 M | 130.76% |
| 2015-12-31 | $36.46 M | 119.76% |
| 2014-12-31 | $16.59 M |